Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Eur J Clin Nutr ; 69(10): 1133-9, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25626407

RESUMEN

BACKGROUND/OBJECTIVES: The objective of this study was to examine the relationship between upper distribution levels of glucose values in the 75-g oral glucose tolerance test (OGTT) and recommended diagnostic criteria for gestational diabetes mellitus (GDM) and adverse pregnancy outcomes. SUBJECTS/METHODS: The distribution of the OGTT 2-h values of 13,501 pregnant women, which were below the World Health Organization (WHO) threshold for overt diabetes mellitus (DM), and managed in one teaching hospital in China, was reviewed and related to maternal characteristics and pregnancy outcomes. RESULTS: For the entire group, the 90th and 95th percentile values of the OGTT 2-h glucose level, respectively, were close to the diagnostic cutoff values of the WHO and International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. For adverse maternal outcomes, glucose level above the 90th percentile value was associated with increased hypertensive disorders, whereas no difference was seen with cutoff using the 95th percentile value. For perinatal outcomes, the 90th percentile was associated with increased neonatal intensive care unit admission and hypoglycemia, whereas the 95th percentile showed in addition association with phototherapy for jaundice and 5th-minute Apgar score <7. Although no differences in the incidence of adverse pregnancy outcomes were found using the different cutoffs, the >95th percentile cutoff value would have missed out 33.3-56.7% of the cases of adverse outcomes that would otherwise have been attributed to GDM. CONCLUSIONS: Further studies are warranted to clarify which diagnostic criterion is most appropriate universally to identify adverse pregnancy outcomes attributed to GDM, and which could be mitigated with treatment specific for GDM.


Asunto(s)
Glucemia/metabolismo , Diabetes Gestacional , Prueba de Tolerancia a la Glucosa , Resultado del Embarazo , Tercer Trimestre del Embarazo , Adulto , China , Diabetes Gestacional/sangre , Diabetes Gestacional/diagnóstico , Femenino , Humanos , Hipertensión/etiología , Hipoglucemia/etiología , Recién Nacido , Cuidado Intensivo Neonatal , Ictericia/etiología , Embarazo , Valores de Referencia
2.
Psychol Med ; 44(14): 2927-37, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25065859

RESUMEN

BACKGROUND: Because cerebral morphological abnormalities in major depressive disorder (MDD) may be modulated by antidepressant treatment, inclusion of medicated patients may have biased previous meta-analyses of voxel-based morphometry (VBM) studies. A meta-analysis of VBM studies on medication-free MDD patients should be able to distinguish the morphological features of the disease itself from those of treatment. METHOD: A systematic search was conducted for the relevant studies. Effect-size signed differential mapping was applied to analyse the grey matter differences between all medication-free MDD patients and healthy controls. Meta-regression was used to explore the effects of demographics and clinical characteristics. RESULTS: A total of 14 datasets comprising 400 medication-free MDD patients and 424 healthy controls met the inclusion criteria. The pooled meta-analysis and subgroup meta-analyses showed robustly reduced grey matter in prefrontal and limbic regions in MDD. Increased right thalamus volume was only seen in first-episode medication-naive patients, and increased grey matter in the bilateral anterior cingulate cortex only in medication wash-out patients. In meta-regression analyses the percentage of female patients in each study was negatively correlated with reduced grey matter in the right hippocampus. CONCLUSIONS: By excluding interference from medication effects, the present study identified grey matter reduction in the prefrontal-limbic network in MDD. The subgroup meta-analysis results suggest that an increased right thalamus volume might be a trait directly related to MDD, while an increased anterior cingulate cortex volume might be an effect of medication. The meta-regression results perhaps reveal the structural underpinning of the sex differences in epidemiological and clinical aspects of MDD.


Asunto(s)
Trastorno Depresivo Mayor/patología , Sustancia Gris/patología , Sistema Límbico/patología , Imagen por Resonancia Magnética , Corteza Prefrontal/patología , Tálamo/patología , Femenino , Humanos , Masculino
3.
Sci Sin ; 24(8): 1166-78, 1981 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-6272389

RESUMEN

Although there are unequivocal evidences indicating the participation of endogenous opiate-like substances in acupuncture analgesia, their exact sites of action remain to be elucidated. From the results of localization studies by injecting minute amount of narcotic antagonist naloxone into discrete brain areas and assessing its effect on acupuncture analgesia in rabbits it is concluded that nuclei accumbens, amygdala, habenula and periaquaductal grey are the strategic sites for endogenous opioids to exert their analgesic effect. These brain areas are also of extreme importance for the realization of morphine analgesia.


Asunto(s)
Terapia por Acupuntura , Analgesia , Morfina/antagonistas & inhibidores , Naloxona/farmacología , Amígdala del Cerebelo/fisiología , Animales , Endorfinas/fisiología , Masculino , Microinyecciones , Naloxona/administración & dosificación , Núcleo Accumbens/fisiología , Dolor/fisiopatología , Conejos , Receptores Opioides/efectos de los fármacos , Umbral Sensorial
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA